Yonatan Peleg

1.4k total citations
12 papers, 547 citations indexed

About

Yonatan Peleg is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Yonatan Peleg has authored 12 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 4 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Yonatan Peleg's work include Renal Diseases and Glomerulopathies (10 papers), Chronic Kidney Disease and Diabetes (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Yonatan Peleg is often cited by papers focused on Renal Diseases and Glomerulopathies (10 papers), Chronic Kidney Disease and Diabetes (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Yonatan Peleg collaborates with scholars based in United States. Yonatan Peleg's co-authors include Pietro A. Canetta, Satoru Kudose, Ali G. Gharavi, Vivette D. D’Agati, Jonathan Barasch, Glen S. Markowitz, Maddalena Marasà, Katherine Xu, Ibrahim Batal and Dominick Santoriello and has published in prestigious journals such as Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology and ChemBioChem.

In The Last Decade

Yonatan Peleg

9 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yonatan Peleg United States 6 327 248 126 121 84 12 547
Moh’d A. Sharshir United States 5 295 0.9× 217 0.9× 139 1.1× 92 0.8× 85 1.0× 8 455
Yuriy Khanin United States 5 251 0.8× 131 0.5× 122 1.0× 85 0.7× 76 0.9× 8 400
Elisa Delbarba Italy 7 223 0.7× 185 0.7× 46 0.4× 117 1.0× 55 0.7× 13 435
Erol Demir Türkiye 12 131 0.4× 96 0.4× 61 0.5× 44 0.4× 42 0.5× 59 344
Noriko Ammerman United States 13 104 0.3× 66 0.3× 168 1.3× 57 0.5× 33 0.4× 22 466
Sam Kant United States 13 98 0.3× 85 0.3× 84 0.7× 25 0.2× 89 1.1× 48 422
Jun B. Lee United States 7 75 0.2× 58 0.2× 194 1.5× 38 0.3× 47 0.6× 9 585
Arnaud Devresse Belgium 10 88 0.3× 54 0.2× 94 0.7× 37 0.3× 44 0.5× 51 357
Lucile Amrouche France 13 107 0.3× 108 0.4× 263 2.1× 11 0.1× 62 0.7× 32 674
Anju Yadav United States 13 71 0.2× 124 0.5× 111 0.9× 14 0.1× 20 0.2× 39 477

Countries citing papers authored by Yonatan Peleg

Since Specialization
Citations

This map shows the geographic impact of Yonatan Peleg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonatan Peleg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonatan Peleg more than expected).

Fields of papers citing papers by Yonatan Peleg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonatan Peleg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonatan Peleg. The network helps show where Yonatan Peleg may publish in the future.

Co-authorship network of co-authors of Yonatan Peleg

This figure shows the co-authorship network connecting the top 25 collaborators of Yonatan Peleg. A scholar is included among the top collaborators of Yonatan Peleg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonatan Peleg. Yonatan Peleg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Peleg, Yonatan, Miroslav Sekulic, Jae‐Hyung Chang, et al.. (2024). C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after Transplantation. Clinical Journal of the American Society of Nephrology. 19(8). 1005–1015. 6 indexed citations
2.
Kanduri, Swetha Rani, Yonatan Peleg, & Shikha Wadhwani. (2024). Liver Disease–Associated Glomerulopathies. PubMed. 31(2). 147–156. 1 indexed citations
3.
Ahmad, Syeda B., Yonatan Peleg, & Wooin Ahn. (2023). Current approaches to overcome recurrent focal segmental glomerulosclerosis after kidney transplantation. Current Opinion in Nephrology & Hypertension. 33(1). 61–66.
4.
Ellis, Carla L., et al.. (2022). A Rare Case of Granulomatous Interstitial Nephritis in a Patient With COVID-19. Journal of Investigative Medicine High Impact Case Reports. 10. 1615962261–1615962261. 1 indexed citations
5.
Vissing, Andrew, et al.. (2022). Screening for Anti-Rituximab Antibody in Management of Rituximab Refractory PLA2R-Associated Membranous Nephropathy. Journal of the American Society of Nephrology. 33(11S). 505–506.
6.
Rosen, Raphael J., et al.. (2021). Proton Pump Inhibitor (PPI) for the Treatment of Metabolic Alkalosis due to Gastric Losses. Journal of the American Society of Nephrology. 32(10S). 386–386.
7.
Peleg, Yonatan, Andrew S. Bomback, Pietro A. Canetta, et al.. (2021). Late Relapses of Membranous Nephropathy: A Case Series. Kidney360. 2(6). 974–982. 2 indexed citations
8.
Kudose, Satoru, Dominick Santoriello, Andrew S. Bomback, et al.. (2021). Longitudinal Outcomes of COVID-19–Associated Collapsing Glomerulopathy and Other Podocytopathies. Journal of the American Society of Nephrology. 32(11). 2958–2969. 41 indexed citations
9.
Peleg, Yonatan, Andrew S. Bomback, & Jai Radhakrishnan. (2020). The Evolving Role of Calcineurin Inhibitors in Treating Lupus Nephritis. Clinical Journal of the American Society of Nephrology. 15(7). 1066–1072. 19 indexed citations
10.
Peleg, Yonatan, Satoru Kudose, Vivette D. D’Agati, et al.. (2020). Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection. Kidney International Reports. 5(6). 940–945. 167 indexed citations
11.
Kudose, Satoru, Ibrahim Batal, Dominick Santoriello, et al.. (2020). Kidney Biopsy Findings in Patients with COVID-19. Journal of the American Society of Nephrology. 31(9). 1959–1968. 279 indexed citations
12.
Peleg, Yonatan, Biliang Hu, Argentina Ornelas, et al.. (2016). Directed Evolution of Scanning Unnatural‐Protease‐Resistant (SUPR) Peptides for in Vivo Applications. ChemBioChem. 17(17). 1643–1651. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moh’d A. Sharshir Breakdown of academic impact, for papers by Yuriy Khanin Breakdown of academic impact, for papers by Elisa Delbarba Breakdown of academic impact, for papers by Erol Demir Breakdown of academic impact, for papers by Noriko Ammerman Breakdown of academic impact, for papers by Sam Kant Breakdown of academic impact, for papers by Jun B. Lee Breakdown of academic impact, for papers by Arnaud Devresse Breakdown of academic impact, for papers by Lucile Amrouche Breakdown of academic impact, for papers by Anju Yadav
Rankless by CCL
2026